首页 › 基金 › STEMPOINT CAPITAL LP › RLMD
STEMPOINT CAPITAL LP 对 RLMD 的持仓历史
RELMADA THERAPEUTICS INC · 医疗保健
STEMPOINT CAPITAL LP 在 Q2 2026 的 13F 申报中披露持有 RLMD(RELMADA THERAPEUTICS INC)1,460,093 股,市值约 US$10.1M,约占其申报组合的 2.24%,在其申报持仓中市值排名第 17 位。 STEMPOINT CAPITAL LP 最近 2 个申报季度中有 2 个季度披露了 RLMD 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
STEMPOINT CAPITAL LP 对 RLMD 的持仓演变
STEMPOINT CAPITAL LP 于 Q1 2026 首次披露 RLMD 持仓:597,409 股(约 US$4.2M)。 该持仓在 Q2 2026 达到峰值 1,460,093 股,市值约 US$10.1M。 在 2 次申报中,STEMPOINT CAPITAL LP 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 1,460,093 股、市值约 US$10.1M,环比增持 862,684 股。。 持仓曾出现大幅变动:Q2 2026 增持约 144% (随后一个季度股价下跌 46%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 597.41K | $4.16M | 新进 |
| Q2 2026 | 1.46M | $10.10M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RLMD 与 13F 数据
RLMD(RELMADA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 76 只申报持有 RLMD,申报仓位最大的包括:Squadron Capital Management LLC (US$50.9M), Venrock Adviser, LLC (US$47.4M), Spruce Street Capital LP (US$44.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RLMD 的基金
- Squadron Capital Management LLC 7.35M 股 · $50.86M · Q2 2026
- Venrock Adviser, LLC 6.84M 股 · $47.36M · Q2 2026
- Spruce Street Capital LP 6.39M 股 · $44.23M · Q2 2026
- Jones Hill Capital LP 3.66M 股 · $25.29M · Q2 2026
- Ikarian Capital, LLC 2.15M 股 · $14.87M · Q2 2026
- Commodore Capital LP 1.43M 股 · $9.86M · Q2 2026
- Sio Capital Management, LLC 1.00M 股 · $6.94M · Q2 2026
- Opaleye Management Inc. 935.00K 股 · $6.47M · Q2 2026
- Boxer Capital Management, LLC 842.11K 股 · $5.83M · Q2 2026
- GREAT POINT PARTNERS LLC 842.11K 股 · $5.83M · Q2 2026
- Knott David M Jr 451.00K 股 · $3.12M · Q2 2026
- HighVista Strategies LLC 445.80K 股 · $3.08M · Q2 2026
更多关于 STEMPOINT CAPITAL LP
常见问题
How long has STEMPOINT CAPITAL LP held RLMD?
STEMPOINT CAPITAL LP has disclosed RLMD holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is STEMPOINT CAPITAL LP's current position in RLMD?
As of Q2 2026, STEMPOINT CAPITAL LP holds 1.46M shares of RLMD (RELMADA THERAPEUTICS INC), valued at $10.10M, representing 2.24% of its reported portfolio and ranking #17.
Has STEMPOINT CAPITAL LP been buying or selling RLMD?
In the latest 13F filing (Q2 2026), STEMPOINT CAPITAL LP increased its position in RLMD. The position peaked in Q2 2026 at 1.46M shares.
Which other funds hold RLMD?
Other major institutional holders of RLMD include Squadron Capital Management LLC, Venrock Adviser, LLC, Spruce Street Capital LP, among 76 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.